These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 32274720)
1. Heparanase is Involved in Leukocyte Migration. Higashi N; Irimura T; Nakajima M Adv Exp Med Biol; 2020; 1221():435-444. PubMed ID: 32274720 [TBL] [Abstract][Full Text] [Related]
2. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate. Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189 [TBL] [Abstract][Full Text] [Related]
3. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275 [TBL] [Abstract][Full Text] [Related]
4. An iminosugar-based heparanase inhibitor heparastatin (SF4) suppresses infiltration of neutrophils and monocytes into inflamed dorsal air pouches. Sue M; Higashi N; Shida H; Kogane Y; Nishimura Y; Adachi H; Kolaczkowska E; Kepka M; Nakajima M; Irimura T Int Immunopharmacol; 2016 Jun; 35():15-21. PubMed ID: 27015605 [TBL] [Abstract][Full Text] [Related]
5. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. Benhamron S; Nechushtan H; Verbovetski I; Krispin A; Abboud-Jarrous G; Zcharia E; Edovitsky E; Nahari E; Peretz T; Vlodavsky I; Mevorach D J Immunol; 2006 Jun; 176(11):6417-24. PubMed ID: 16709798 [TBL] [Abstract][Full Text] [Related]
6. Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium. Lever R; Rose MJ; McKenzie EA; Page CP Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1184-90. PubMed ID: 24740543 [TBL] [Abstract][Full Text] [Related]
7. Implications of heparan sulfate and heparanase in neuroinflammation. Zhang X; Wang B; Li JP Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase. Bartlett MR; Underwood PA; Parish CR Immunol Cell Biol; 1995 Apr; 73(2):113-24. PubMed ID: 7797231 [TBL] [Abstract][Full Text] [Related]
9. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400 [TBL] [Abstract][Full Text] [Related]
10. Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation. Stoler-Barak L; Petrovich E; Aychek T; Gurevich I; Tal O; Hatzav M; Ilan N; Feigelson SW; Shakhar G; Vlodavsky I; Alon R FASEB J; 2015 May; 29(5):2010-21. PubMed ID: 25634957 [TBL] [Abstract][Full Text] [Related]
11. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Mollinedo F; Nakajima M; Llorens A; Barbosa E; Callejo S; Gajate C; Fabra A Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):917-23. PubMed ID: 9581574 [TBL] [Abstract][Full Text] [Related]
12. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation. Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527 [TBL] [Abstract][Full Text] [Related]
13. Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies. Komatsu N; Waki M; Sue M; Tokuda C; Kasaoka T; Nakajima M; Higashi N; Irimura T J Immunol Methods; 2008 Feb; 331(1-2):82-93. PubMed ID: 18162185 [TBL] [Abstract][Full Text] [Related]
14. Role of endothelial heparanase in delayed-type hypersensitivity. Edovitsky E; Lerner I; Zcharia E; Peretz T; Vlodavsky I; Elkin M Blood; 2006 May; 107(9):3609-16. PubMed ID: 16384929 [TBL] [Abstract][Full Text] [Related]
15. Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells. Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Jiang H; Mikkelsen T; Chopp M J Exp Clin Cancer Res; 2008 Jul; 27(1):23. PubMed ID: 18647407 [TBL] [Abstract][Full Text] [Related]
16. Expression of heparanase in nestin-positive reactive astrocytes in ischemic lesions of rat brain after transient middle cerebral artery occlusion. Takahashi H; Matsumoto H; Kumon Y; Ohnishi T; Freeman C; Imai Y; Tanaka J Neurosci Lett; 2007 May; 417(3):250-4. PubMed ID: 17368723 [TBL] [Abstract][Full Text] [Related]
17. Heparanase: Historical Aspects and Future Perspectives. Khanna M; Parish CR Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707 [TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses. Ferro V Expert Opin Ther Targets; 2013 Aug; 17(8):965-75. PubMed ID: 23789629 [TBL] [Abstract][Full Text] [Related]
19. Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. Sotnikov I; Hershkoviz R; Grabovsky V; Ilan N; Cahalon L; Vlodavsky I; Alon R; Lider O J Immunol; 2004 May; 172(9):5185-93. PubMed ID: 15100255 [TBL] [Abstract][Full Text] [Related]
20. Heparan sulphate as a regulator of leukocyte recruitment in inflammation. Kumar AV; Katakam SK; Urbanowitz AK; Gotte M Curr Protein Pept Sci; 2015; 16(1):77-86. PubMed ID: 25692849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]